Stock listing

Euglena Co., Ltd.

Selected listing: A1KCNK · LS · EUR · DE

Euglena Co., Ltd. (Lang & Schwarz: A1KCNK), Health Technology. Latest release Aug 7, 2026: [Summary]Consolidated Financial Results for the Six Months Ended…

A1KCNK:LSEURDEUpdated October 3, 2026

Ticker: Lang & Schwarz: A1KCNK
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Euglena Co., Ltd.

[Summary]Consolidated Financial Results for the Six Months Ended June 30, 2026 (Under Japanese GAAP)

August 7, 2026

Euglena : Summary of Consolidated Financial Results for the Six Months Ended June 30, 2022 (Based on Japanese GAAP)

August 16, 2022

Euglena : Summary of Consolidated Financial Results for the Year Ended December 31, 2021 (Based on Japanese GAAP)

February 22, 2022

Euglena : Summary of Consolidated Financial Results for the Twelve Months Ended September 30, 2021(Based on Japanese GAAP)

November 25, 2021

Euglena : Summary of Consolidated Financial Results for the Nine Months Ended June 30, 2021 (Based on Japanese GAAP)

August 30, 2021

All Euglena Co., Ltd. news →

Research Euglena Co., Ltd.

Euglena Co., Ltd. company profile

View the public company page for Euglena Co., Ltd. on 6ix.

Euglena Co., Ltd. news

Read company news and market updates connected to Euglena Co., Ltd..

Euglena Co., Ltd. investor events

Find investor webinars, events, and replay context for Euglena Co., Ltd..